Skip to main content
. 2021 Oct 19;41:101155. doi: 10.1016/j.eclinm.2021.101155

Table 3.

Pooled outcomes of the included studies in the subgroup analyses. Subgroup analyses suggested that male sex, underlying conditions (obesity, congenital heart disease, and chronic pulmonary disease), clinical symptoms and complications (ARDS, MIS-C, shortness of breath, gastrointestinal symptoms, and the need for intensive care), and biomarkers (CRP level at baseline) were associated with poor prognosis in children and adolescents with COVID-19. While, there was not statistical significance observed for other factors.

Risk factor No. of studies reporting the factor Total no. of patients Effect size (95% CI) I2 Quality of evidence (GRADE)
Death
Need for intensive care 1 409 OR 352.46 (20.75, 5985.86) 100% LOW
Age less than ten years 2 489 OR 4.56 (1.17, 17.71) 100% VERY LOW
Admitted to intensive care unit
Suspected or confirmed ARDS 2 607 OR 28.44 (7.61, 106.25) 16.8% MODERATE
Age less than one month 3 1621 OR 2.29 (1.48, 3.56) 0% LOW
Congenital heart disease 2 991 OR 2.76 (1.04, 7.30) 0% LOW
Obesity 2 668 OR 2.42 (1.09, 5.40) 0% LOW
Gastrointestinal symptoms 2 66 OR 2.01 (1.29, 3.13) 0% LOW
Shortness of breath 1 991 OR 6.27 (1.57, 25.05) 100% LOW
Male sex 4 1688 OR 1.34 (1.01, 1.80) 0% VERY LOW
Underlying conditions 3 1622 OR 2.83 (1.58, 5.06) 71.7% VERY LOW
Chronic pulmonary disease 1 582 OR 3.17 (1.23, 8.22) 100% VERY LOW
MIS-C 1 409 OR 2.35 (1.27, 4.34) 100% VERY LOW
CRP/mg/L (at baseline) 1 66 WMD 125.80 (37.04, 214.56) 100% VERY LOW
Receiving respiratory support
Shortness of breath 1 435 OR 16.96 (7.66, 37.51) 100% LOW
Progression to severe or critical disease
Confirmed ARDS 1 98 OR 56.43 (10.27, 310.00) 100% LOW

We did subgroup analyses for cohort and case-control studies with high and medium quality; OR: odds ratio; WMD: weighted mean difference; CI: confidence interval; ARDS: acute respiratory distress syndrome; CRP: C-reactive protein; GRADE: grading of recommendations assessment, development, and evaluation; MIS-C: multisystem inflammatory syndrome.